2278 related articles for article (PubMed ID: 32785815)
21. Acceptability of a COVID-19 vaccine among adults in the United States: How many people would get vaccinated?
Reiter PL; Pennell ML; Katz ML
Vaccine; 2020 Sep; 38(42):6500-6507. PubMed ID: 32863069
[TBL] [Abstract][Full Text] [Related]
22. Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity Outcomes: Interim Analysis of 2 Randomized Clinical Trials.
Xia S; Duan K; Zhang Y; Zhao D; Zhang H; Xie Z; Li X; Peng C; Zhang Y; Zhang W; Yang Y; Chen W; Gao X; You W; Wang X; Wang Z; Shi Z; Wang Y; Yang X; Zhang L; Huang L; Wang Q; Lu J; Yang Y; Guo J; Zhou W; Wan X; Wu C; Wang W; Huang S; Du J; Meng Z; Pan A; Yuan Z; Shen S; Guo W; Yang X
JAMA; 2020 Sep; 324(10):951-960. PubMed ID: 32789505
[TBL] [Abstract][Full Text] [Related]
23. Vaccination Against Severe Acute Respiratory Syndrome Coronavirus 2.
Plotkin SA
J Pediatric Infect Dis Soc; 2020 Nov; 9(5):517-518. PubMed ID: 32744616
[TBL] [Abstract][Full Text] [Related]
24. Attitudes of healthcare workers towards COVID-19 vaccination: a survey in France and French-speaking parts of Belgium and Canada, 2020.
Verger P; Scronias D; Dauby N; Adedzi KA; Gobert C; Bergeat M; Gagneur A; Dubé E
Euro Surveill; 2021 Jan; 26(3):. PubMed ID: 33478623
[TBL] [Abstract][Full Text] [Related]
25. Understanding COVID-19 vaccine efficacy.
Lipsitch M; Dean NE
Science; 2020 Nov; 370(6518):763-765. PubMed ID: 33087460
[No Abstract] [Full Text] [Related]
26. Progress and Concept for COVID-19 Vaccine Development.
Wu SC
Biotechnol J; 2020 Jun; 15(6):e2000147. PubMed ID: 32304139
[No Abstract] [Full Text] [Related]
27. Covid-19 vaccines: Should we allow human challenge studies to infect healthy volunteers with SARS-CoV-2?
McPartlin SO; Morrison J; Rohrig A; Weijer C
BMJ; 2020 Nov; 371():m4258. PubMed ID: 33168564
[No Abstract] [Full Text] [Related]
28. Planning for a COVID-19 Vaccination Program.
Schaffer DeRoo S; Pudalov NJ; Fu LY
JAMA; 2020 Jun; 323(24):2458-2459. PubMed ID: 32421155
[No Abstract] [Full Text] [Related]
29. Keeping track of the SARS-CoV-2 vaccine pipeline.
Parker EPK; Shrotri M; Kampmann B
Nat Rev Immunol; 2020 Nov; 20(11):650. PubMed ID: 32989290
[TBL] [Abstract][Full Text] [Related]
30. COVID-19 vaccine development: Time to consider SARS-CoV-2 challenge studies?
Schaefer GO; Tam CC; Savulescu J; Voo TC
Vaccine; 2020 Jul; 38(33):5085-5088. PubMed ID: 32540271
[TBL] [Abstract][Full Text] [Related]
31. Unnecessary hesitancy on human vaccine tests.
Eyal N
Science; 2020 Jul; 369(6500):150-151. PubMed ID: 32646991
[No Abstract] [Full Text] [Related]
32. The Race to Develop a COVID-19 Vaccine.
Am J Nurs; 2020 Oct; 120(10):14-15. PubMed ID: 32976132
[TBL] [Abstract][Full Text] [Related]
33. Unnecessary hesitancy on human vaccine tests-Response.
Shah SK; Miller FG; Darton TC; Duenas D; Emerson C; Lynch HF; Jamrozik E; Jecker NS; Kamuya D; Kapulu M; Kimmelman J; MacKay D; Memoli MJ; Murphy SC; Palacios R; Richie TL; Roestenberg M; Saxena A; Saylor K; Selgelid MJ; Vaswani V; Rid A
Science; 2020 Jul; 369(6500):151. PubMed ID: 32646992
[No Abstract] [Full Text] [Related]
34. Out of the frying pan and into the fire? Due diligence warranted for ADE in COVID-19.
Coish JM; MacNeil AJ
Microbes Infect; 2020 Oct; 22(9):405-406. PubMed ID: 32590062
[TBL] [Abstract][Full Text] [Related]
35. Attitudes towards influenza, and COVID-19 vaccines during the COVID-19 pandemic among a representative sample of the Jewish Israeli population.
Maor Y; Caspi S
PLoS One; 2022; 17(2):e0255495. PubMed ID: 35148322
[TBL] [Abstract][Full Text] [Related]
36. Evaluating and Deploying Covid-19 Vaccines - The Importance of Transparency, Scientific Integrity, and Public Trust.
Schwartz JL
N Engl J Med; 2020 Oct; 383(18):1703-1705. PubMed ID: 32966716
[No Abstract] [Full Text] [Related]
37. Planning for COVID-19 vaccines safety surveillance.
Kochhar S; Salmon DA
Vaccine; 2020 Sep; 38(40):6194-6198. PubMed ID: 32684499
[TBL] [Abstract][Full Text] [Related]
38. Attitudes towards Anti-SARS-CoV2 Vaccination among Healthcare Workers: Results from a National Survey in Italy.
Di Gennaro F; Murri R; Segala FV; Cerruti L; Abdulle A; Saracino A; Bavaro DF; Fantoni M
Viruses; 2021 Feb; 13(3):. PubMed ID: 33652829
[TBL] [Abstract][Full Text] [Related]
39. Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines.
Lambert PH; Ambrosino DM; Andersen SR; Baric RS; Black SB; Chen RT; Dekker CL; Didierlaurent AM; Graham BS; Martin SD; Molrine DC; Perlman S; Picard-Fraser PA; Pollard AJ; Qin C; Subbarao K; Cramer JP
Vaccine; 2020 Jun; 38(31):4783-4791. PubMed ID: 32507409
[TBL] [Abstract][Full Text] [Related]
40. Audio Interview: Guidelines for Covid-19 Vaccine Deployment.
Rubin EJ; Baden LR; Morrissey S
N Engl J Med; 2020 Sep; 383(11):e88. PubMed ID: 32905696
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
